|
Sign In to gain access to subscriptions and/or personal tools.
|
Studies of the effect of Pall leucocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system
PJ Thurlow
Departments of Haematology and Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia
L. Doolan
Departments of Haematology and Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia
R. Sharp
Departments of Haematology and Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia
M. Sullivan
Departments of Haematology and Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia
B. Smith
Departments of Haematology and Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia
Neutrophil activation is thought to play a major role in the inflammatory response seen in reperfusion injury and similar clinical situations, i.e. extracorporeal circulation. lmpairment of neutrophil function or reduction of total numbers of neutrophils using a leucocyte filter may be beneficial in reducing the adverse clinical effects.
In this study we have investigated the effect of the Pall LG6 and control AV6 filters during simulated in vitro cardiopulmonary bypass (CPB). Various parameters were evaluated including neutrophils, total leucocytes, monocytes, lymphocytes and platelets, expression of antigens on neutrophils using a panel of leucocyte-associated monoclonal antibodies CD13, 14, 15, 45Ro, 67,11a, 11 b and L selectin. The effects of leucocyte stimulation with phorbol myristate acetate (PMA) and a leucocyte bolus from a patient with chronic myeloid leukaemia (CML) were also investigated.
We have demonstrated that the LG6 significantly reduces leucocytes, in particular neutrophils, with a modest reduction of lymphocytes, platelets and haematocrit, whereas the AV6 had no effect on leukocytes or neutrophils in the test system. In addition the LG6 was associated with a reduction in expression of all leucocyte antigens by approximately 20%; however there was no appreciable alteration of any of the antigens with AV6. Leucocyte stimulation with PMA resulted in a dramatic decrease of all cellular elements and an extra leucocyte load (using CML leucocytes) was not effectively filtered by the LG6 filter.
These studies identify the capacity of the LG6 as compared with the AV6 to deplete activated neutrophils in an in vitro simulated cardiopulmonary bypass circuit.
Perfusion, Vol. 10, No. 5,
291-300 (1995)
DOI: 10.1177/026765919501000503
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Gourlay, A. H. Olivencia-Yurvati, and S. Gunaydin
STS Blood Conservation Guidelines: The Role of Leukocyte Filtration
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
1138 - 1139.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou
The effects of various leukocyte filtration strategies in cardiac surgery
Eur. J. Cardiothorac. Surg.,
April 1, 2007;
31(4):
665 - 676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Schneider, T. Sakert, J. Lucke, P. McKeown, and A. Sharma
Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency
Perfusion,
March 1, 2006;
21(2):
117 - 120.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Ilmakunnas, E. J. Pesonen, J. Ahonen, J. Ramo, S. Siitonen, and H. Repo
Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg.,
April 1, 2005;
129(4):
851 - 859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hamamoto, M. Suga, T. Nakatani, Y. Takahashi, Y. Sato, S. Inamori, T. Yagihara, and S. Kitamura
Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model
Eur. J. Cardiothorac. Surg.,
May 1, 2004;
25(5):
833 - 838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S V Sheppard, R V Gibbs, and D C Smith
Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production?
Perfusion,
January 1, 2004;
19(1):
7 - 10.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. A Ortolano, G. S Aldea, K. Lilly, P. O'Gara, J. D Alkon, F. Madera, T. Murad, C. P Altenbern, C. S Tritt, A. Capetandes, et al.
A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects
Perfusion,
March 1, 2002;
17(2_suppl):
53 - 62.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D C Whitaker, J A Stygall, S P Newman, and M J. Harrison
The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies
Perfusion,
December 1, 2001;
16(6):
433 - 446.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Fabbri, J. Manfredi, C. Piccin, G. Soffiati, M. R. Carta, E. Gasparotto, and G. Nardon
Systemic leukocyte filtration during cardiopulmonary bypass
Perfusion,
January 1, 2001;
16(1_suppl):
11 - 18.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. M. Langley, P. J. Chai, S. S. Tsui, J. J. Jaggers, and R. M. Ungerleider
THE EFFECTS OF A LEUKOCYTE-DEPLETING FILTER ON CEREBRAL AND RENAL RECOVERY AFTER DEEP HYPOTHERMIC CIRCULATORY ARREST
J. Thorac. Cardiovasc. Surg.,
June 1, 2000;
119(6):
1262 - 1269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V A Gant, J May, D F Treacher, K Morris, and K Berrill
A novel leucocyte-depleting filter for use in continuous venovenous haemofiltration: preliminary in vitro studies
Perfusion,
December 1, 1998;
13(6):
437 - 446.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Asimakopoulos and K. M. Taylor
Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
Ann. Thorac. Surg.,
December 1, 1998;
66(6):
2135 - 2144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A J Heggie, J S Corder, P R Crichton, J W Hesford, H Bingham, S Jeffries, and T L Hooper
Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1)
Perfusion,
January 1, 1998;
13(1):
17 - 25.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Allen
Leucocyte depletion in cardiothoracic surgery
Perfusion,
May 1, 1996;
11(3):
270 - 277.
[PDF]
|
|
|
|
|
